Cambridge Investment Research Advisors’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $58K | Buy |
27,967
+100
| +0.4% | +$207 | ﹤0.01% | 3528 |
|
|
2025
Q1 | $61K | Buy |
27,867
+17,500
| +169% | +$38.3K | ﹤0.01% | 3393 |
|
|
2024
Q4 | $16K | Sell |
10,367
-1,300
| -11% | -$2.01K | ﹤0.01% | 3432 |
|
|
2024
Q3 | $23K | Sell |
11,667
-3,200
| -22% | -$6.31K | ﹤0.01% | 3361 |
|
|
2024
Q2 | $52K | Buy |
14,867
+4,000
| +37% | +$14K | ﹤0.01% | 3215 |
|
|
2024
Q1 | $30K | Sell |
10,867
-1,000
| -8% | -$2.76K | ﹤0.01% | 3247 |
|
|
2023
Q4 | $20K | Sell |
11,867
-3,750
| -24% | -$6.32K | ﹤0.01% | 3143 |
|
|
2023
Q3 | $16K | Sell |
15,617
-1,900
| -11% | -$1.95K | ﹤0.01% | 3092 |
|
|
2023
Q2 | $20K | Sell |
17,517
-500
| -3% | -$571 | ﹤0.01% | 3125 |
|
|
2023
Q1 | $27K | Buy |
18,017
+700
| +4% | +$1.05K | ﹤0.01% | 3084 |
|
|
2022
Q4 | $43K | Sell |
17,317
-1,000
| -5% | -$2.48K | ﹤0.01% | 2996 |
|
|
2022
Q3 | $77K | Hold |
18,317
| – | – | ﹤0.01% | 2893 |
|
|
2022
Q2 | $51K | Sell |
18,317
-1,500
| -8% | -$4.18K | ﹤0.01% | 2940 |
|
|
2022
Q1 | $113K | Buy |
19,817
+41
| +0.2% | +$234 | ﹤0.01% | 2999 |
|
|
2021
Q4 | $181K | Buy |
19,776
+4,540
| +30% | +$41.6K | ﹤0.01% | 2917 |
|
|
2021
Q3 | $163K | Buy |
15,236
+31
| +0.2% | +$332 | ﹤0.01% | 2860 |
|
|
2021
Q2 | $236K | Buy |
+15,205
| New | +$236K | ﹤0.01% | 2675 |
|